Polish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

FOCUS:Families OverComing Under Stress

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły
Zaloguj się Zarejestruj się
Link zostanie zapisany w schowku
StatusZakończony
Sponsorzy
Cedars-Sinai Medical Center

Słowa kluczowe

Abstrakcyjny

The FOCUS program (study treatment) is an established evidence-based intervention whose redesign for families and couples dealing with serious and chronic illnesses will provide a creative and promising supplement to the existing support services at Cedars-Sinai Medical Center. All participants will receive the 10-weeks of 75-minute weekly study treatment, but will be split into two groups, the immediate treatment group and the wait list treatment group, who will receive the study treatment after the immediate 10 weeks of treatment is completed.

Opis

Despite advances in the development of brief evidence-based programs for families and couples contending with illness, trauma or loss, the support services provided at even top-tier medical facilities are overwhelmingly focused on the individual patient. In most cases, combined treatment with spouses and family members is the exception rather than the rule.

FOCUS is one of the very few programs that has a strong evidence base and has been used in medical settings. It is a preventive, skill-based training program that is customized for each couple or family and is designed to build upon existing strengths in order to enhance family and individual resilience.

A cancer diagnosis is a family affair. Research has shown that the family or spousal relationship can be instrumental in lessening patient distress and supporting treatment compliance and positive adjustment across the various stages of treatment, survivorship, recurrence / relapse, and end-of-life. Reductions in patient depression and anxiety through couple or family interventions may reduce overall healthcare utilization and cost while improving care quality.

Daktyle

Ostatnia weryfikacja: 01/31/2019
Pierwsze przesłane: 12/11/2016
Szacowana liczba przesłanych rejestracji: 12/11/2016
Wysłany pierwszy: 12/13/2016
Ostatnia aktualizacja przesłana: 02/04/2019
Ostatnia opublikowana aktualizacja: 02/06/2019
Rzeczywista data rozpoczęcia badania: 12/04/2016
Szacowana data zakończenia podstawowej działalności: 05/17/2018
Szacowana data zakończenia badania: 05/17/2018

Stan lub choroba

Cancer
Depression
PostTraumatic Stress Disorder
Anxiety

Interwencja / leczenie

Behavioral: FOCUS Resilience Enhancement Program

Behavioral: Waitlist Treatment

Faza

-

Grupy ramion

RamięInterwencja / leczenie
Experimental: FOCUS Resilience Enhancement Program
Those assigned to the immediate treatment group will participate in the 10-week treatment.
Behavioral: FOCUS Resilience Enhancement Program
Each couple or family will have 10 weekly 75 minute sessions comprising the treatment protocol.Questionnaires will be administered at baseline-before the immediate treatment phase (T1) and after the 10-week treatment is completed (T2).
Experimental: Waitlist Treatment
After the 10-week immediate treatment period, wait-list control participants will be administered the treatment.
Behavioral: Waitlist Treatment
Participants assigned to the Waitlist (No Treatment) group will receive the study intervention only after the 10 weeks of the immediate treatment phase has been completed. Questionnaires will be administered at baseline-before the immediate treatment phase (T1) and after the immediate treatment phase is completed (T2).

Kryteria kwalifikacji

Wiek kwalifikujący się do nauki 5 Years Do 5 Years
Płeć kwalifikująca się do naukiAll
Przyjmuje zdrowych wolontariuszytak
Kryteria

Inclusion Criteria:

Written informed consent will be obtained from each participating adult subject and written assent from each minor participating in the program. Specific criteria for inclusion into the program are as follows:

1. Couples must have at least one partner and families at least one parent who is or has been diagnosed with cancer at least 30 days prior to study start and not more than one year from last treatment visit.

2. Couples or parents must be at least 18 years old and must be English speakers.

3. At least one member of the couple must score >60 on the Anxiety or Depression scale on the Brief Symptom Index 18 administered during the screening visit and/or have notable difficulties in relationship or family functioning, as resulted in a ≥2 score in FAD subscale or at least one RDAS subscale question answered 'more often than not' or more frequent.

4. The families participating in the study must have at least one child older than the age of five.

5. Participating families must have at least one parent who can provide legal consent for the participation of their child(ren) in the program.

6. Participants must be willing and able to complete 10 sessions within 14 weeks.

7. Participants undergoing active management or care plans for abuse or psychopathology may enroll in study if reports of ongoing management are provided.

Exclusion Criteria:

1. There must not be any participant with urgent and/or immediate health needs (where a possible 10-week wait time poses more than minimal risks).

2. There must not be active (within the last 30 days and/or during study intervention) and unmanaged domestic violence or abuse, substance abuse, or extreme forms of psychopathology such as psychosis that would interfere with the treatment.

3. Primary presenting personal and/or relational issues are largely unrelated to the cancer diagnosis and treatment, as determined by the screening clinician.

Wynik

Podstawowe miary wyników

1. Feasibility of program as defined by dropout rate [10 weeks]

A randomized controlled trial will be considered feasible if the dropout rate is less than or equal to 20%.

Miary wyników wtórnych

1. Change in score of depression as measured by the Patient Health Questionnaire 9 (PHQ-9). [10 weeks]

2. Change in score of anxiety as measured by the General Anxiety Disorder 7 (GAD-7). [10 weeks]

3. Change in score of post traumatic stress as measured by the PTSD Checklist - Civilian (PCL-C). [10 weeks]

4. Change in score of stress in Human Functioning as measured by the Sense of Coherency (SOC). [10 weeks]

5. Change in score of quality of life as measured by the Functional Assessment of Cancer Therapy - General Version (FACT-G). [10 weeks]

6. Change in score of caregiver's quality of life as measured by the Caregiver Quality of Life Index - Cancer (CQOLC). [10 weeks]

7. Change in score of family functioning as measured by the McMasters Family Assessment Device (FAD). [10 weeks]

8. Change in score of couples relational functioning as measured by the Revised Dyadic Adjustment Scale (RDAS). [10 weeks]

9. Change in parents' score of child functioning as measured by the Strengths and Difficulties Questionnaire (SDQ). [10 weeks]

10. Change in patient satisfaction score as measured by the FOCUS Impact Rating Scale (FIRS). [10 weeks]

Dołącz do naszej strony
na Facebooku

Najbardziej kompletna baza danych ziół leczniczych poparta naukowo

  • Działa w 55 językach
  • Ziołowe leki poparte nauką
  • Rozpoznawanie ziół na podstawie obrazu
  • Interaktywna mapa GPS - oznacz zioła na miejscu (wkrótce)
  • Przeczytaj publikacje naukowe związane z Twoim wyszukiwaniem
  • Szukaj ziół leczniczych po ich działaniu
  • Uporządkuj swoje zainteresowania i bądź na bieżąco z nowościami, badaniami klinicznymi i patentami

Wpisz objaw lub chorobę i przeczytaj o ziołach, które mogą pomóc, wpisz zioło i zobacz choroby i objawy, na które są stosowane.
* Wszystkie informacje oparte są na opublikowanych badaniach naukowych

Google Play badgeApp Store badge